Two patients diagnosed with coexisting hematologic and oncologic BRAF V600E mutated malignancies. Which entity is really carrying the BRAF (V600E) mutation?

Schlick, K, Troch, M, Placher-Sorko, G, Faber, V, Neureiter, D, Greil, R, Hopfinger, G ONKOLOGIE. 2013, 36: 168-169.

MESENCHYMAL STEM CELLS RETAIN THEIR PRO-OLIGODENDROGENIC ACTIVITY DURING AGING: A RATIONALE FOR AUTOLOGOUS TRANSPLANTATION IN MULTIPLE SCLEROSIS

Rivera, FJ, Wodnar, R, Feichtner, M, Oberbauer, E, Brachtl, G, Greil, R, Rohde, E, Franklin, RJM, Aigner, L GLIA. 2013, 61: S52-S52.

Lapatinib plus Caelyx in patients with advanced or metastatic Her 2 positive breast cancer following failure of Trastuzumab therapy – A Phase II study of the Arbeitsgemeinschaft Medikamentose Tumortherapie

Pircher, M, Mlineritsch, B, Fridrik, M, Dittrich, C, Lang, A, Petru, E, Weltermann, A, Thaler, J, Hufnagl, C, Gampenrieder, SP, Ressler, S, Rinnerthaler, G, Ulmer, H, Greil, R ONKOLOGIE. 2013, 36: 159-159.

„ABCSG C-07 EXERCISE – Pilot study“: Endurance exercise to reduce the recurrence rate after adjuvant chemotherapy for colorectal cancer

Piringer, G, Fridrik, M, Fridrik, A, Zabernigg, A, Greil, R, Eisterer, W, Tschmelitsch, J, Lang, A, Gnant, M, Thaler, J ONKOLOGIE. 2013, 36: 72-72.

Aktuelle Diagnostik und Therapieoptionen bei aggressiven Lymphomen.

Hopfinger, G, Greil, R Bremen, London, Boston: UniMed Verlag, 2013. (ISBN: 978-3-8374-1407-3)

Bid-ding for mercy: twisted killer in action.

Egle A, Asslaber D, Villunger A, Pinon-Hofbauer J. Cell Death and Differentiation. 2013 Jul,20(7):847-9. doi: 10.1038/cdd.2013.40.

[Autoimmune hemolysis accompanied by thrombopenia: consumption or myelodysplasia?].

Melchardt, T, Weiss, L, Egle, A, Dtsch Med Wochenschr. 2013 Oct,138(41):2093-5. doi: 10.1055/s-0033-1349586. Epub 2013 Oct 1.

Mycophenolatmofetil und Azathioprin in der Schwangerschaft bei einer Patientin mit systemischem Lupus erythematodes.

Psenak, O, Studnicka-Benke, A, Greil, R Rheuma plus. 2013, 12: 18-20.

p53 Efficiently Suppresses Tumor Development in the Complete Absence of Its Cell-Cycle Inhibitory and Proapoptotic Effectors p21, Puma, and Noxa.

Valente LJ, Gray DH, Michalak EM, Pinon-Hofbauer J, Egle A, Scott CL, Janic A, Strasser A. Cell Rep. 2013 May 30,3(5):1339-45. doi: 10.1016/j.celrep.2013.04.012. Epub 2013 May 9.

Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck.

Keil F, Selzer E, Berghold A, Reinisch S, Kapp KS, De Vries A, Greil R, Bachtiary B, Tinchon C, Anderhuber W, Burian M, Kasparek AK, Elsäßer W, Kainz H, Riedl R, Kopp M, Kornek G. Eur J Cancer. 2013 Jan,49(2):352-9. doi: 10.1016/j.ejca.2012.08.004. Epub 2012 Sep 14.